Foseco Crucible Q1 FY27 Results (BSE: 523160)

3 Aug 2026 · Analysis by Alpha Inflection

Signal: Margin expansion

The read

First-quarter results show a sharp inflection from the FY26 trend: revenue grew 14.4% YoY (reversing a 11.7% FY26 decline), and EBITDA margin surged 1,200 bps YoY to 38.4% on the back of raw material cost relief and operating leverage from near-flat employee costs and declining other expenses. PAT of ₹10.29 Cr (up 78% YoY) absorbed a ₹1.14 Cr asset impairment charge. The margin improvement appears structural if input costs stay favourable, but the impairment signals possible past overinvestment. The board reshuffle in July 2026 adds governance uncertainty.

P&L walk

Revenue growth of 14.4% YoY combined with sharp raw material deflation (RM % fell 600 bps) and strict fixed-cost control drove a 1,200 bps YoY expansion in EBITDA margin to 38.4%; PAT of ₹10.29 Cr was boosted by operating leverage, even after a ₹1.14 Cr asset impairment charge.

Key positives

• Revenue grew 14.4% YoY, breaking the declining trend of the past 3 years (3yr CAGR -1.3%).
• EBITDA margin expanded 1,200 bps YoY to 38.4%, driven by raw material cost tailwind (RM% fell 600bps) and operating leverage (fixed costs grew <1% while revenue grew 14.4%).
• PAT increased 78.3% YoY to ₹10.29 Cr, despite a ₹1.14 Cr impairment charge.
• EPS of ₹18.38 is the highest in recent quarters (vs Q1FY26 ₹10.31).
• Gross margin improved 656 bps YoY to 72.1%, indicating pricing power or input deflation.

Key concerns

• Revenue QoQ growth of 30.3% is partly seasonal; Q4 is typically weak.
• The company booked a ₹1.14 Cr impairment on manufacturing assets, suggesting some capacity may be underutilised or obsolete.
• Recent board instability: three directors appointed and three resigned in late July 2026, including an independent director.
• 3-year revenue CAGR still negative at -1.3%, indicating long-term demand challenges.

View original filing

Research and educational content only. Not investment advice.